Sign in
NUVB-WT Stock Price, Chart, Stats & News
Nuvation Bio Inc.
Save
23.95M
Market cap
–
Current P/E
–
Forward P/E
NUVB-WT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 86.58% |
Operating margin | -338.72% |
Pretax margin | -325.31% |
Net margin | -325.31% |
Effective tax rate | – |
ROA | -34.40% |
ROE | -57.48% |
D/E | 0.03x |
Interest coverage ratio | -27.86x |
NUVB-WT valuation
P/E | – |
P/S | 23.42x |
P/B | 4.79x |
P/CF | -8.44x |
P/FCF | -8.48x |
P/OCF | -8.44x |
PEG | -1.14x |
EV multiple | -8.31x |
About
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for oncology. The company's pipeline includes small molecule drug candidates aimed at treating various types of cancer. Its strategy involves acquiring and developing novel therapeutic candidates to address significant unmet medical needs in cancer treatment.
Similar securities
Based on sector and market capitalization
Report issue